The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model

Marianne G. Pouwer, Elsbet J. Pieterman, Lars Verschuren, Martien P. M. Caspers, Cornelis Kluft, Ricardo A. Garcia, Jurjan Aman, J. Wouter Jukema, Hans M. G. Princen

Research output: Contribution to journalArticleAcademicpeer-review

52 Citations (Scopus)
Original languageEnglish
Article number55
JournalFrontiers in cardiovascular medicine
Volume5
DOIs
Publication statusPublished - 12 Jun 2018

Keywords

  • animal model cardiovascular disease
  • atherosclerosis
  • cardiovascular side effects
  • cholesterol
  • chronic myeloid leukemia
  • coagulation/thrombosis
  • lipids and lipoprotein metabolism

Cite this